I have been reading the forum for the past week or so and I think were all in this stock for the long hall. RNA is currently being investigated by two or three law firms for possible Securities and Exchange Commission violations on behalf of its share holders. One of things there investigating are statements issued on behalf of RNA concerning its daily operations and financial prospects. So any news about drugs currently undergoing clinical trials probably will not come out until the investigation is done because it could come back to haunt them in court, especially positive news about drisapersen since it would go against a previous statement by the company that said the drug is showing no significant effect. Its not that they do not have any PR about the drug, it is just now is not the time to release it.